TAilored Post-Surgical Therapy in Early Stage NSCLC

NCT00775385 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Standard Chemotherapy
DRUG: Customized Treatment

Sponsor

Intergroupe Francophone de Cancerologie Thoracique